Literature DB >> 10801952

Zinc-altered immune function and cytokine production.

L Rink1, H Kirchner.   

Abstract

Although the intriguing role of zinc as an essential trace element for immune function is well established, particular progress in determining the molecular principles of action of this ion was made recently. Leukocyte responsiveness is delicately regulated by zinc concentration. Zinc deficiency as well as supraphysiologic levels impair immune function. Furthermore, the activities of many immunostimulants frequently used in immunologic studies are influenced by zinc concentration. Therefore, our knowledge from in vitro studies is widely dependent on the zinc concentration, and when not in physiologic range, immunologic responses are artificially low. Decreased production of TH1 cytokines and interferon-alpha by leukocytes in the healthy elderly person is correlated with low zinc serum level. The defect in interferon-alpha production is reconstituted by the addition of physiologic amounts of zinc in vitro. Interestingly, zinc induces cytokine production by isolated leukocytes. Zinc induces monocytes to produce interleukin-1, interleukin-6 and tumor necrosis factor-alpha in peripheral blood mononuclear cells and separated monocytes. This effect is higher in serum-free medium. However, only in the presence of serum does zinc also induce T cells to produce lymphokines. This effect on T cells is mediated by cytokines produced by monocytes. Stimulation also requires cell-to-cell contact of monocytes and T cells. Information is presented to illustrate the concepts that the zinc concentration must be taken into account whenever in vitro studies are made or complex alterations of immune functions are observed in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801952     DOI: 10.1093/jn/130.5.1407S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  35 in total

1.  Zinc increases the phagocytic capacity of canine peripheral blood phagocytes in vitro.

Authors:  You-Joung Kim; Ji-Houn Kang; Mhan-Pyo Yang
Journal:  Vet Res Commun       Date:  2008-09-09       Impact factor: 2.459

Review 2.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

3.  A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.

Authors:  Jessica Kenney; Rachel Singer; Nina Derby; Meropi Aravantinou; Ciby J Abraham; Radhika Menon; Samantha Seidor; Shimin Zhang; Agegnehu Gettie; James Blanchard; Michael Piatak; Jeffrey D Lifson; José A Fernández-Romero; Thomas M Zydowsky; Melissa Robbiani
Journal:  AIDS Res Hum Retroviruses       Date:  2012-07-30       Impact factor: 2.205

Review 4.  Internal parasite management in grazing livestock.

Authors:  Niranjan Kumar; Thakur Krishan Shankar Rao; Anju Varghese; Veer Singh Rathor
Journal:  J Parasit Dis       Date:  2012-12-11

5.  Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response.

Authors:  Juan P Liuzzi; Louis A Lichten; Seth Rivera; Raymond K Blanchard; Tolunay Beker Aydemir; Mitchell D Knutson; Tomas Ganz; Robert J Cousins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-29       Impact factor: 11.205

6.  The influence of zinc in mice on infection with Angiostrongylus cantonensis.

Authors:  Chun-Hsiang Chen; Yeou-Lih Huang; Chuan-Min Yen
Journal:  Parasitol Res       Date:  2004-07-31       Impact factor: 2.289

7.  Immunomodulative effect of glucan and/or glucan supplemented with zinc in albendazole therapy for murine alveolar echinococcosis.

Authors:  Jarmila Porubcová; Emília Dvoroznáková; Zuzana Sevcíková
Journal:  Parasitol Res       Date:  2007-05-12       Impact factor: 2.289

8.  Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation.

Authors:  Tom H Karlsen; Halvor Sommerfelt; Skjalg Klomstad; Per Kragh Andersen; Tor A Strand; Rune J Ulvik; Christina Ahrén; Harleen M S Grewal
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Glycemic control of type 2 diabetic patients after short-term zinc supplementation.

Authors:  Hyun-Mee Oh; Jin-Sook Yoon
Journal:  Nutr Res Pract       Date:  2008-12-30       Impact factor: 1.926

Review 10.  Low zinc status: a new risk factor for pneumonia in the elderly?

Authors:  Junaidah B Barnett; Davidson H Hamer; Simin N Meydani
Journal:  Nutr Rev       Date:  2010-01       Impact factor: 7.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.